Cancers | Feature Papers from the First Half of 2024 in the Section “Cancer Therapy”
As Cancers (ISSN: 2072-6694) is an open access journal, you have free and unlimited access to the full text of all articles. We welcome you to read our feature papers from the first half of 2024 in the Section “Cancer Therapy”, which are listed below:
1. “The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy”
by Corrado Tinterri, Bethania Fernandes, Alberto Zambelli, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Shadya Sara Darwish, Flavia Jacobs, Camilla De Carlo, Martina Iuzzolino et al.
Cancers 2024, 16(2), 376; https://doi.org/10.3390/cancers16020376
Available online: https://www.mdpi.com/2072-6694/16/2/376
2. “Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy”
by Ryungsa Kim, Takanori Kin and William T. Beck
Cancers 2024, 16(5), 984; htpps://doi.org/10.3390/cancers16050984
Available online: https://www.mdpi.com/2072-6694/16/5/984
3. “Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials”
by Jinjiang Wang, Jiaxi Li, Jiao Liu, Kit-Ying Chan, Ho-Sze Lee, Kenneth Nansheng Lin, Chi-Chiu Wang and Tat-San Lau
Cancers 2024, 16(3), 512; htpps://doi.org/10.3390/cancers16030512
Available online: https://www.mdpi.com/2072-6694/16/3/512
4. “Targeted Therapeutic Strategies for the Treatment of Cancer”
by Benjamin Victoir, Cécile Croix, Fabrice Gouilleux and Gildas Prié
Cancers 2024, 16(2), 461; htpps://doi.org/10.3390/cancers16020461
Available online: https://www.mdpi.com/2072-6694/16/2/461
5. “Prognosis and Treatment of Gastric Cancer: A 2024 Update”
by Claudia Burz, Vlad Pop, Ciprian Silaghi, Iulia Lupan and Gabriel Samasca
Cancers 2024, 16(9), 1708; htpps://doi.org/10.3390/cancers16091708
Available online: https://www.mdpi.com/2072-6694/16/9/1708
6. “Exploring Helium Ions’ Potential for Post-Mastectomy Left-Sided Breast Cancer Radiotherapy”
by Santa Gabriella Bonaccorsi, Thomas Tessonnier, Line Hoeltgen, Eva Meixner, Semi Harrabi, Juliane Hörner-Rieber, Thomas Haberer, Amir Abdollahi, Jürgen Debus and Andrea Mairani
Cancers 2024, 16(2), 410; htpps://doi.org/10.3390/cancers16020410
Available online: https://www.mdpi.com/2072-6694/16/2/410
7. “Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions”
by Rohan Kalyan Rej, Joyeeta Roy and Srinivasa Rao Allu
Cancers 2024, 16(3), 552; htpps://doi.org/10.3390/cancers16030552
Available online: https://www.mdpi.com/2072-6694/16/3/552
8. “Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma”
by Charles B. Nguyen, Eugene Oh, Piroz Bahar, Ulka N. Vaishampayan, Tobias Else and Ajjai S. Alva
Cancers 2024, 16(3), 601; htpps://doi.org/10.3390/cancers16030601
Available online: https://www.mdpi.com/2072-6694/16/3/601
9. “Management of Hepatocellular Carcinoma in 2024: The Multidisciplinary Paradigm in an Evolving Treatment Landscape”
by Emily Kinsey and Hannah M. Lee
Cancers 2024, 16(3), 666; htpps://doi.org/10.3390/cancers16030666
Available online: https://www.mdpi.com/2072-6694/16/3/666
10. “Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer”
by Natalia Andryszak, Daria Świniuch, Elżbieta Wójcik, Rodryg Ramlau, Marek Ruchała and Rafał Czepczyński
Cancers 2024, 16(3), 667; https://doi.org/10.3390/cancers16030667
Available online: https://www.mdpi.com/2072-6694/16/3/667
You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.
Cancers Editorial Office